You are here: Home » News-CM » Companies » News
Business Standard

Sun Pharma Advanced Research Company to increase authorised share capital

Capital Market 

From Rs 32.50 cr to Rs 37.50 cr

Sun Pharma Advanced Research Company announced that it received shareholders approval on 30 September 2020 for increase in authorized share capital of the company from the present Rs. 32,50,00,000/- divided into 32,50,00,000 Equity Shares of Re. 1/- each to Rs. 37,50,00,000/- divided into 37,50,00,000 Equity Shares of Re. 1/- each.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, October 03 2020. 10:13 IST